Yahoo
OTC Markets OTCPK - Delayed Quote USD

Ludwig Enterprises, Inc. (LUDG)

0.0040 0.0000 (0.00%)
At close: October 28 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for LUDG
  • Previous Close 0.0040
  • Open 0.0050
  • Bid 0.0014 x 15000000
  • Ask 0.0040 x 5902200
  • Day's Range 0.0040 - 0.0050
  • 52 Week Range 0.0030 - 0.0750
  • Volume 2,934
  • Avg. Volume 8,137
  • Market Cap (intraday) 668,667
  • Beta (5Y Monthly) 1.51
  • PE Ratio (TTM) 0.40
  • EPS (TTM) 0.0100
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Ludwig Enterprises, Inc. operates as a genomic technology focused on developing testing approaches for inflammation-related chronic diseases, including cancers in the United States. The company integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits for cancer identification. It offers mRNA-based screening to provide early insights of potential health risks. The company develops Revealia Breast test, a non-invasive cheek swab screening kit designed to identify and analyze molecular signatures in mRNA expression associated with inflammation-related biological processes associated with the presence of breast cancer. Ludwig Enterprises, Inc. was founded in 1988 and is based in Miami, Florida.

ludwigent.com

5

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

LUDG
92.31%
S&P 500 (^GSPC)
12.78%

1-Year Return

LUDG
91.49%
S&P 500 (^GSPC)
12.04%

3-Year Return

LUDG
98.10%
S&P 500 (^GSPC)
87.51%

5-Year Return

LUDG
86.67%
S&P 500 (^GSPC)
67.64%

Statistics

View More

Valuation Measures

Annual
As of 10/28/2026
  • Market Cap

    585.08k

  • Enterprise Value

    3.27M

  • Trailing P/E

    0.35

  • Forward P/E

    --

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -149.48%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -1.48M

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    18.32k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    823.71k

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: